PIER 88 INVESTMENT PARTNERS LLC

Position in KRYS — Krystal Biotech, Inc.

CIK 1697366 SAN FRANCISCO, CA

Position in KRYS

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$892,008

-$12,112 QoQ

Shares Held

2,400

-31.4% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

1.15%

of 13F equity value

Holder Rank

#199

of 419 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PIER 88 INVESTMENT PARTNERS LLC holds $6,341,408 across 13 Biotechnology names. KRYS ranks #1 (14.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc. This page	2,400	$892,008
2	LGND	Ligand Pharmaceuticals Inc	2,600	$821,834
3	MDGL	Madrigal Pharmaceuticals, Inc.	1,300	$698,035
4	HALO	Halozyme Therapeutics, Inc.	8,500	$665,295
5	ABCL	AbCellera Biologics Inc.	79,900	$627,215
6	ABSI	Absci Corp	42,500	$492,575
7	BBIO	BridgeBio Pharma, Inc.	6,300	$469,224
8	CORT	Corcept Therapeutics Inc	4,100	$356,495

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$892,008	2,400	-31.4%	Shares	Sole	2026-08-04
2026-03-31	$904,120	3,500	-11.8%	Shares	Sole	2026-05-11
2025-12-31	$978,763	3,970	+3.9%	Shares	Sole	2026-02-04
2025-09-30	$674,344	3,820	0.0%	Shares	Sole	2025-10-31
2025-06-30	$525,097	3,820	-13.8%	Shares	Sole	2025-08-07
2025-03-31	$798,729	4,430	+18.1%	Shares	Sole	2025-05-06
2024-12-31	$587,475	3,750	+6.2%	Shares	Sole	2025-02-12
2024-09-30	$642,565	3,530	+5.1%	Shares	Sole	2024-11-06
2024-06-30	$617,030	3,360	+187.2%	Shares	Sole	2024-08-06
2024-03-31	$208,178	1,170	0.0%	Shares	Sole	2024-05-10
2023-12-31	$145,150	1,170	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.